复宏汉霖(02696.HK)获复星医药增持14.86万股_老虎社区_美港股上老虎

复宏汉霖(02696.HK)获复星医药增持14.86万股

金融界网站2023-04-11

　　格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。

　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

虎头虎脑之鹰击长空
·2023-04-12
这个
回复
点赞
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2326119647?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-04-11 06:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2326119647","market":"sh","top_or_hot":-1,"title":"复宏汉霖(02696.HK)获复星医药增持14.86万股","media":"金融界网站","content":"<html><body><div><p>　　格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，<a href=\"https://laohu8.com/S/02696\">复宏汉霖</a>(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。</p><p>　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。</p>\n<div>\n</div>\n</div></body></html>","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复宏汉霖(02696.HK)获复星医药增持14.86万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复宏汉霖(02696.HK)获复星医药增持14.86万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-11 06:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://hk.jrj.com.cn/2023/04/11064737465795.shtml><strong>金融界网站</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co.,...</p>\n\n<a href=\"http://hk.jrj.com.cn/2023/04/11064737465795.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0060","symbol_name":"抗癌","start_time":0,"source_url":"http://hk.jrj.com.cn/2023/04/11064737465795.shtml","article_id":"2326119647","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2326119647","pubTimestamp":1681166841,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600196":"复星医药","BK0060":"抗癌","BK0183":"MSCI概念","BK0187":"一线龙头","BK0239":"医药制造","BK0012":"证金概念","02696":"复宏汉霖","BK0196":"行业龙头","BK1191":"制药","BK1515":"抗疫概念","BK1161":"生物科技","BK1593":"医美概念股","BK0175":"白马股","BK0028":"国家队","BK0096":"民营医院","02196":"复星医药","BK0188":"融资融券"},"translate_title":"Fuhong Hanlin (02696. HK) was increased by 148,600 shares by Fosun Pharma","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600196":1,"02196":1,"02696":1},"content_text":"格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":653715872,"gmtCreate":1681273876397,"gmtModify":1681273877883,"author":{"id":"4098320575389210","authorId":"4098320575389210","name":"虎头虎脑之鹰击长空","avatar":"https://static.tigerbbs.com/0cc990f6c7bc363a015b013ff9572be1","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"4098320575389210","authorIdStr":"4098320575389210"},"htmlText":"这个","listText":"这个","text":"这个","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/653715872","repostId":2326119647,"repostType":2,"repost":{"id":"2326119647","kind":"news","pubTimestamp":1681166841,"share":"https://www.laohu8.com/m/news/2326119647?lang=&edition=full","pubTime":"2023-04-11 06:47","market":"sh","language":"zh","title":"复宏汉霖(02696.HK)获复星医药增持14.86万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2326119647","media":"金融界网站","summary":"格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。","content":"<html><body><div><p>　　格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，<a href=\"https://laohu8.com/S/02696\">复宏汉霖</a>(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。</p><p>　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。</p>\n<div>\n</div>\n</div></body></html>","source":"jinrongjie_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复宏汉霖(02696.HK)获复星医药增持14.86万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复宏汉霖(02696.HK)获复星医药增持14.86万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-04-11 06:47 北京时间&nbsp;&nbsp;&nbsp;<a href=http://hk.jrj.com.cn/2023/04/11064737465795.shtml><strong>金融界网站</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co.,...</p>\n\n<a href=\"http://hk.jrj.com.cn/2023/04/11064737465795.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"600196":"复星医药","BK0060":"抗癌","BK0183":"MSCI概念","BK0187":"一线龙头","BK0239":"医药制造","BK0012":"证金概念","02696":"复宏汉霖","BK0196":"行业龙头","BK1191":"制药","BK1515":"抗疫概念","BK1161":"生物科技","BK1593":"医美概念股","BK0175":"白马股","BK0028":"国家队","BK0096":"民营医院","02196":"复星医药","BK0188":"融资融券"},"source_url":"http://hk.jrj.com.cn/2023/04/11064737465795.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2326119647","content_text":"格隆汇4月11日丨根据联交所最新权益披露资料显示，2023年4月3日-4月4日，复宏汉霖(02696.HK)获Shanghai Fosun Pharmaceutical (Group) Co., Ltd.在场内以每股均价11.3422-11.9749港元合计增持14.86万股，涉资约173.25万港元。　　增持后，Shanghai Fosun Pharmaceutical (Group) Co., Ltd.最新持股数目为3430.92万股，持股比例由20.90%上升至20.99%。","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}